Questcor Pharmaceuticals (QCOR): Q1 EPS of $0.58 beats by $0.06. Revenue of $96M (+161% Y/Y)...

This news story has 2 comments:

Register or Login to rate comments »

Ernest P Icahn Comments (199)
 
Sequentially terrible! Gap up, then get ready for the sell off.
24 Apr 2012, 04:34 PM Reply Like

floorwall Comments (2)
 
I spent sometime looking at this stock....and I don't get it....one drug which does not even have a patent, originally developed in 1952, made from pig pituitary glands, manufactured at Cangene, and sold only to one customer, a subsidiary of EsRx....and I am looking at the numbers now....this seems like Herb Greenberg should be all over this one!
4 May 2012, 04:29 AM Reply Like